TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibition of EGF receptorMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 10nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-4(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of erbB4 receptorMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 26nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 49nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 49nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 70nMAssay Description:Inhibition of erbB2 overexpressing BT 474 cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 90nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 97nMAssay Description:Inhibition of erbB2 overexpressing HB4a.e5.2 cell proliferationMore data for this Ligand-Target Pair
TargetEpidermal growth factor receptor(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 210nMAssay Description:Inhibition of EGF receptor overexpressing HN5 cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 290nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 290nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 350nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 390nMAssay Description:Inhibition of erbB2 overexpressing Calu3 cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 390nMAssay Description:Inhibition of erbB2 overexpressing Calu3 cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 560nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.10E+3nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.30E+3nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 1.86E+3nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 3.10E+3nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 4.40E+3nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Rattus norvegicus)
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 6.60E+3nMAssay Description:Inhibition of rat Receptor protein-tyrosine kinase erbB2More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 1(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: >8.00E+3nMAssay Description:Inhibition of Cyclin-dependent kinase 1More data for this Ligand-Target Pair
TargetCyclin-dependent kinase 2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: >8.00E+3nMAssay Description:Inhibition of Cyclin-dependent kinase 2More data for this Ligand-Target Pair
TargetDual specificity mitogen-activated protein kinase kinase 1/2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 9.70E+3nMAssay Description:Inhibition of erbB2 overexpressing BT 474 cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 2.10E+4nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetReceptor tyrosine-protein kinase erbB-2(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 2.70E+4nMAssay Description:Inhibition of c-erbB-2 overexpressing HB4a cell proliferationMore data for this Ligand-Target Pair
TargetRAF proto-oncogene serine/threonine-protein kinase(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: 4.90E+4nMAssay Description:Inhibition of Raf kinaseMore data for this Ligand-Target Pair
TargetProto-oncogene tyrosine-protein kinase Src(Homo sapiens (Human))
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Research Biomet. Glaxo Wellcome Medicines Research Centre
Curated by ChEMBL
Affinity DataIC50: >5.00E+4nMAssay Description:Inhibition of Src kinaseMore data for this Ligand-Target Pair